Patents by Inventor Max Chaffanet

Max Chaffanet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MARKER OF BREAST TUMORS FROM THE LUMINAL-B SUBTYPE
    Publication number: 20160017439
    Abstract: An in vitro method for diagnosing a breast cancer from the luminal-B subtype in a female, includes the steps of analyzing a biological sample from the female by (i) determining the copies number of the ZNF703 gene, and/or (ii) determining the expression of the ZNF703 gene, wherein an increased copies number and/or an over-expression of the ZNF703 gene is indicative of a luminal B tumor; to a kit for diagnosing a breast cancer from the luminal-B subtype in a female including at least one nucleic acid probe or oligonucleotide or at least one antibody, which can be used in a method as defined previously, for determining the copies number of the ZNF703 gene, and/or determining the expression of the ZNF703 gene; and to the use of such a kit.
    Type: Application
    Filed: September 22, 2015
    Publication date: January 21, 2016
    Inventors: Daniel BIRNBAUM, Max CHAFFANET, Christophe GINESTIER, Jose ADELAIDE, Fabrice COULOMB
  • MARKER OF BREAST TUMORS FROM THE LUMINAL-B SUBTYPE
    Publication number: 20130295571
    Abstract: An in vitro method for diagnosing a breast cancer from the luminal-B subtype in a female, includes the steps of analyzing a biological sample from the female by (i) determining the copies number of the ZNF703 gene, and/or (ii) determining the expression of the ZNF703 gene, wherein an increased copies number and/or an over-expression of the ZNF703 gene is indicative of a luminal B tumor; to a kit for diagnosing a breast cancer from the luminal-B subtype in a female including at least one nucleic acid probe or oligonucleotide or at least one antibody, which can be used in a method as defined previously, for determining the copies number of the ZNF703 gene, and/or determining the expression of the ZNF703 gene; and to the use of such a kit.
    Type: Application
    Filed: October 28, 2011
    Publication date: November 7, 2013
    Applicant: INSTITUT NATIONAL DE LA SANTEE ET DE LA RECHERCHE MEDICALE ( INSERM)
    Inventors: Daniel Birnbaum, Max Chaffanet, Christophe Ginestier, Jose Adelaide, Fabrice Sircoulomb